[Form 10-K (Mark one) x For the fiscal year ended: December 31, 2009 o For the transition period from ______________ to _____________ China Pharma Holdings, Inc. Delaware 73-1564807 (State or other jurisdiction (I.R.S. Employer I.D. No.) incorporation or organization) 2nd Floor, No. 17, Jinpan Road, Haikou, Hainan Province, China 570216 0086-898-66811730 (China) None Securities registered under Section 12(b) of the] [Anhui Fuyang Xinte Pharmaceutical Company , S ales Contract Name of Product Quality standard and specification Unit Unit price Quantity Amount(RMB) Tiopronin kg 1200.00 1000 1200000 Hepatocyte growth—promoting factor kg 9000.00 40 3600000 Micro-fiber products 33.00 8000 264000 Medicinal Starch 4.6 5000 23000 Pre-gel starch 8.5 4000 34000 Total amount Five million one hundred and twenty one thousand only 5,121,000.00] [Raw Material Purchase / Sales Contract Date signed : 2009-03-25 Place: Haikou Accordingly to friendly negotiation, both Parties agree to the term and condition stated as following, 1 Name, specification, quantity and total amount of product Name of Product Quality standard and specification Unit Unit price Quantity Amount(RMB) Brain tissue initial liquid ml 2.00 873,950 1,747,900.00 FDHB mg 400.00 7,300] [Sale s Contract of Helpson Medical & Biotechnology Co., Ltd. C ontract No. Signed at: Arrival port: C ustom No.: B usiness No.: According to the related stipulation of "People's Republic of China Law of contract", after consulting unanimously, both sides sign this contract: NO. Name of Commodity ,Specifications Unit Quantity Unit Price(RMB ) Total Amount Time of Shipment Buflomedil] [Sale s Contract of Helpson Medical & Biotechnology Co., Ltd. C ontract No. Signed at: Arrival port: C ustom No. : B usiness No. : According to the related stipulation of "People's Republic of China Law of contract", after consulting unanimously, both sides sign this contract: NO. Name of Commodity, Specifications Unit Quantity Unit Price(RMB ) Total Amount Time of] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Zhilin Li, certify that: 2) Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with] [CERTIFICATION OF CHIEF FINANC IAL OFFICER OF THE SARBANES-OXLEY ACT OF 2002 I, Frank Waung, certify that: Frank Waung Chief Financial Officer EX-31.2 7 cph10kex312123109.htm] [CERTIFICATION OF CHIEF EXECUTIVE OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Zhilin Li Chief Executive Officer EX-32.1 8 cph10kex321123109.htm] [CERTIFICATION OF CHIEF FINANCIAL OFFICER 18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Frank Waung Chief Financial Officer EX-32.2 9 cph10kex322123109.htm]